In 1979 he joined the European Commission in Brussels and in 1986 became Head of Pharmaceuticals, involved in completion of the European Internal Market and industrial policy in the pharmaceutical sector, as well as trilateral harmonisation of regulatory requirements (ICH) between EC, US and Japan.